Categories AlphaGraphs, Earnings, Health Care
Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today.
Total revenues inched up 1% to $11.5 billion versus the same period a year ago.
Net earnings attributable to BMS were $1.76 billion, or $0.87 per share, compared to $2 billion, or $0.95 per share, last year. Adjusted EPS decreased 7% to $1.70.
For full-year 2024, the company expects revenues to increase by low single-digits and adjusted EPS to range between $7.10-7.40.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
